Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dietary Tryptophan and Metformin Response
NCT02184832Phase 1Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Change in Fasting Glucose at 2 days. Started Aug 2014; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02184832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184832.